Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Anakinra for the treatment of neonatal-onset multisystem inflammatory disease

Nature Clinical Practice Rheumatology volume 2, pages 646–647 (2006)Cite this article

boxed-textGoldbach-Mansky R et al. (2006) Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition. N Engl J Med 355: 581–592

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Agostini L et al. (2004) NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle–Wells autoinflammatory disorder. Immunity 20: 319–325

    Article  CAS  Google Scholar 

  2. Zwerina J et al. (2005) Pathogenesis of rheumatoid arthritis: targeting cytokines. Ann NY Acad Sci 1051: 716–729

    Article  CAS  Google Scholar 

  3. Dinarello C (2005) Blocking IL-1 in systemic inflammation. J Exp Med 201: 1355–1359

    Article  CAS  Google Scholar 

  4. Martinon F et al. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237–241

    Article  CAS  Google Scholar 

  5. Hoffman HM et al. (2004) Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 364: 1779–1785

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Division of Rheumatology, Allergy and Immunology,

    Hal M Hoffman & Gary S Firestein

  2. Clinical Investigation Institute, both at the University of California, San Diego, USA

    Hal M Hoffman & Gary S Firestein

Authors
  1. Hal M Hoffman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gary S Firestein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hal M Hoffman.

Ethics declarations

Competing interests

Dr Hoffman is a Consultant for Regeneron Pharmaceuticals.

GS Firestein declared he has no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoffman, H., Firestein, G. Anakinra for the treatment of neonatal-onset multisystem inflammatory disease. Nat Rev Rheumatol 2, 646–647 (2006). https://doi.org/10.1038/ncprheum0350

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0350

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing